Sharon J. Bracken, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 259 shares at $63.20 ($16K) on 2018-07-23, disclosed to the SEC on 2018-07-24.
Scheduled sale ($16k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABT | SELL | 2018-10-02 | $239K | — | Filing → |
| ABT | SELL | 2018-07-31 | $40K | — | Filing → |
| ABT | SELL | 2018-05-08 | $126K | — | Filing → |